Acquisition (Details) - USD ($) $ in Thousands		12 Months Ended
	Aug. 05, 2019	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Payments to Acquire Intangible Assets		$ 0	$ 0	$ 717
Charges incurred in connection with acquired IPR&D		0	3,353	$ 0
Additional Consideration Disbursement		1,700
Gross Carrying Amount		19,950	18,250
Developed Technology Rights
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gross Carrying Amount		17,324	15,624
Trade Names
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gross Carrying Amount		760	760
WavePoint Peripheral Support Catheters [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Payments to Acquire Intangible Assets			3,353
Charges incurred in connection with acquired IPR&D			$ 3,353
Additional consideration, pending disbursement		$ 1,700
WIRION Embolic Protection System
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Consideration Transferred	$ 16,687
Payments to Acquire Intangible Assets	$ 5,600
Shares issued (in shares)	31,493
Value of shares issued for acquisition	$ 1,346
Additional consideration, pending disbursement	10,000
Potential milestone payment	3
Milestone payment target, increment in net revenues	10
Milestone payment target, excess threshold	$ 30
Milestone payment target, excess threshold, term	36 months
Milestone payment target, excess threshold, term following successful manufacturing transfer	6 months
WIRION Embolic Protection System | Developed Technology Rights
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gross Carrying Amount	$ 15,624
WIRION Embolic Protection System | Trade Names
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gross Carrying Amount	$ 760